SII
Covid-19 vaccination: BJP hits back at Congress, AAP
84% of doses sent abroad are licensing liabilities of Bharat Biotech, SII: Centre
Covishield to cost Rs 400 a dose for states, Rs 600 for private hospitals
SII will serve 50% of the total production to the GoI vaccination program, and remaining will be for State governments and private hospitals
AstraZeneca's COVID-19 vaccine trials continue in India: Serum Institute
AstraZeneca said it has paused global trials, including large late-stage trials, due to an unexplained illness in a study participant
Serum Institute begins phase 2 clinical trial of Oxford COVID vaccine
In all 25 candidates will given the vaccine in the next seven days, according to Dr Lalwani
Serum-Oxford COVID-19 vaccine gets DCGI grant for human trials in India
The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India
Indian firm to test Covid vaccine in 3 weeks; if successful, drug won't be patented
If human clinical trials are successful, product will be out in the market by October